GOLDEN BIOTECHNOLOGY CORP.
Area: Pharmaceutical and Medical Devices
Booth No: R309
Website: https://www.goldenbiotech.com
Exhibitor Profile
Golden Biotechnology Corp. (GoldenBiotech)(4132.TWO), is a leading pharma. company. Antroquinonol is a NCE and distinguished from other developing drugs for COVID-19 by its oral design and multi-functions on anti-viral, anti-inflammation and anti-fibrosis and has been completed Phase 2 trial and unblinded. Granted by FDA Orphan Drug (ODD) for pancreatic cancer, AML and HCC. Pipeline: COVID-19, NSCLC, pancreatic cancer, AML, Alzheimer’s disease, hyperlipidemia, atopic dermatitis and hepatitis B.
Brands
Golden Biotechnology Corp. (GBC, GoldenBiotech)
Video
Exhibit Products
Exhibitor Press Release
- FDA Grants the Pre-EUA Meeting Request by GoldenBiotech’s Applied Antroquinonol to Treat COVID 2022-07-30
- Antroquinonol, Committed to Innovative & Breakthrough Therapy to Improve Quality of Life 2022-07-30
- 2022BioAsiaTaiwan-Golden Biotech Seminar Registration_Innovative Breakthrough_COVID-19 to Oncology 2022-07-27
Exhibitors you may be interested in
Highest Rated